RxDoctor Payments Data

Zachary Barker, DO

Family Medicine · Fulton, MONPI 1760041875

Payments from drug & device makers

$1,402in general payments, 2019–2025

Across 77 payments — averaging $18.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$261
  • Lilly USA, LLC$257
  • AbbVie$193
  • Amgen$185
  • Dexcom, Inc.$88
  • Idorsia Pharmaceuticals US Inc$55
  • plus $364 from 13 others

What the payments were for

  • Food & beverage$1,402100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,402 in reported general payments places this provider in the 70th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$4,445
Medicare patients
107
Services billed
136

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide161$161,078
MounjaroTirzepatide98$103,910
EliquisApixaban102$73,686
FarxigaDapagliflozin Propanediol85$70,471
JardianceEmpagliflozin85$56,439
Breztri AerosphereBudesonide/Glycopyr/Formoterol70$47,163
VraylarCariprazine Hcl27$45,117
JanuviaSitagliptin Phosphate58$40,803
EntrestoSacubitril/Valsartan40$33,083
XareltoRivaroxaban48$27,534
RexultiBrexpiprazole17$23,272
Tresiba Flextouch U-100Insulin Degludec34$19,757
TrulicityDulaglutide20$19,388
Combivent RespimatIpratropium/Albuterol Sulfate22$13,703
TradjentaLinagliptin23$10,837

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$261$161,078161 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$29$123,311181 claims
Lilly USA, LLCMounjaro, Trulicity$257$123,299118 claims
Boehringer IngelheimJardiance, Combivent Respimat, Tradjenta$30$80,979130 claims
PfizerEliquis, Abrysvo$52$79,747122 claims
MerckJanuvia, Janumet, Belsomra$17$57,73191 claims
AbbVieVraylar$193$45,11727 claims
NovartisEntresto$31$33,08340 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Fulton

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →